Description
Pogalizumab Biosimilar - Anti-ACT35 antigen mAb - Research Grade
Target
ACT35 antigen
Target Alias Name
anti-ACT35 antigen/TXGP1L/TAX transcriptionally-activated glycoprotein 1 receptor/Tumor necrosis factor receptor superfamily member 4/TNFRSF4/OX40L receptor/CD134/Vonlerolizumab/ MOXR-0916/ MOXR0916/ RG-7888/ RO7021608
Isotype/Mimetic
IgG1-kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression